Pancreatic ductal adenocarcinoma (PDAC) is predicted to be the second most common
cause of death within the next 10 years. The prognosis for this disease is poor despite …

Pancreatic cancer is a growing source of cancer related death, yet has poor survival rates
which have not improved in the last few decades. Its high mortality rate is attributed to …

Accumulated evidence has revealed that endoscopic ultrasonography (EUS) has had a
great impact on the clinical evaluation of pancreatic cancers. EUS can provide high …

Background and Aims The benefit of rapid on-site evaluation (ROSE) on the diagnostic
accuracy of endoscopic ultrasound–guided fine-needle biopsy (EUS-FNB) has never been …

This manuscript describes the use of ultrasound elastography, with the exception of liver
applications, and represents an update of the 2013 EFSUMB (European Federation of …

For routine EUS-guided sampling of solid masses and lymph nodes (LNs) ESGE
recommends 25G or 22G needles (high quality evidence, strong recommendation); fine …

For pancreatic solid lesions, ESGE recommends performing endoscopic ultrasound (EUS)-
guided sampling as first-line procedure when a pathological diagnosis is required …

Objective The diagnosis of autoimmune pancreatitis (AIP) is challenging. Sonographic and
cross-sectional imaging findings of AIP closely mimic pancreatic ductal adenocarcinoma …

BACKGROUND Cell‐free circulating tumor DNA (ctDNA) in serum has been considered to
be a useful candidate for noninvasive cancer diagnosis. The current study was designed to …

Background and objectives Mucinous cystic neoplasms and intraductal papillary mucinous
tumours have greater malignant potential than serous cystic neoplasms. EUS alone is …